Nodes Logo

Scioto Biosciences, Inc. Announces First Patient Dosed in Phase Ib Study in Patients Diagnosed with Autistic Disorder

August 18, 2021

|

Portfolio Update

SHARE ARTICLE

Get in touch

Contact us for more information about how we can help you invest in healthcare, biotech, climate tech, or advanced systems.